Position in RYTM
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$10,541,854
+$3,640,176 QoQ
Shares Held
94,946
+19.6% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $1,997,986,618 across 85 Biotechnology names. RYTM ranks #54 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
1,096,642 | $134,821,167 | |
| 2 | QURE |
uniQure N.V.
|
2,848,117 | $131,184,269 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,601 | $104,611,833 | |
| 4 | ARGX |
Argenx SE
|
83,822 | $77,767,536 | |
| 5 | ABVX |
Abivax S.A.
|
522,025 | $69,565,051 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
101,566 | $63,330,462 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
646,943 | $61,569,565 | |
| 8 | INSM |
INSMED Inc
|
577,437 | $61,566,331 |
All Filings in RYTM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,541,854 | 94,946 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $6,901,678 | 79,357 | Shares | Defined | 2026-04-29 | |
| 2025-09-30 | $2,700,472 | 26,740 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $4,275,245 | 67,657 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $5,727,593 | 108,129 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,507,341 | 80,517 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $5,909,801 | 112,804 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $4,631,732 | 112,804 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||